Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialWilliam Greenhalf, Markus W. Büchler, John R. Mackey et al.|JNCI Journal of the National Cancer Institute|2013Cited by 333
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, John P. Neoptolemos, Daniel H. Palmer et al.|The Lancet Oncology|2017Cited by 73
PPARα regulates cardiac energy metabolism by controlling malonyl COA concentrations in the heartFiona Campbell, Gary D. Lopaschuk, Alese Wagner et al.|Journal of Molecular and Cellular Cardiology|2001Cited by 0
Low fatty acid oxidation rates in isolated working hearts from PPAR alpha null mice does not impair functional recovery following ischemiaFiona Campbell, Gary D. Lopaschuk, Ray Kozak et al.|Diabetes|2001Cited by 0